-
-
Sio confirms gene therapy company will be liquidated after tough year
-
AstraZeneca’s Alexion hopes to extend dominance in PNH as Big Pharma competitors close in
Takeda’s Poseida partnership starts to pay off with promising hemophilia A gene therapy data
Axonics nabs Canadian nod for 20-year incontinence implant requiring fewer recharges
Gates, Bezos back $75M round for Synchron’s drill-free brain-computer interface implant
In The News
- Economic Storm Clouds Hovering Over Trump and Global Leaders August 25, 2019 By News Team
- UN: Possible to Eradicate Malaria, but Probably Not Soon August 24, 2019 By News Team
- Climate Change Turns Arctic Into Strategic, Economic Hotspot August 23, 2019 By News Team
Biotechnology Daily
more-
Third Harmonic, latest victim of raised liver enzymes, shutters trial and sees shares slide
The curse of raised liver enzymes has struck again, with Third Harmonic the latest company…
Sio confirms gene therapy company will be liquidated after tough year
AstraZeneca’s Alexion hopes to extend dominance in PNH as Big Pharma competitors close in
Takeda’s Poseida partnership starts to pay off with promising hemophilia A gene therapy data
Avidity pushes phase 1/2 data as proof of first targeted RNA into muscle, but FDA partial hold remains
Market Watch
more-
Lam Research to trim 7% of workforce, increase R&D spending as memory-chip crunch hits outlook
Chipmaking equipment company is latest Silicon Valley company to announce cuts
Bio Business News
moreAxonics nabs Canadian nod for 20-year incontinence implant requiring fewer recharges
Hot on the heels of the U.S. launch of its…
Gates, Bezos back $75M round for Synchron’s drill-free brain-computer interface implant
After announcing that it had implanted its brain-computer interface in…
45 days later, BioCryst abandons another program, citing stiff competition
Last month, BioCryst trimmed down its pipeline to two drugs…
World News
moreStocks close with a round of records, Dow clinches 35,000
U.S. stocks swept to another round of records Monday as…
Equifax stock surges toward biggest gain in 12 years after ‘impressive’ business update
Shares of Equifax Inc. EFX, +7.84% shot up 9.3% into…
SpaceX Starlink wins permit to send internet to customers like you
SpaceX has been busy building its Starlink satellite constellation. To…
Third Harmonic, latest victim of raised liver enzymes, shutters trial and sees shares slide
Sio confirms gene therapy company will be liquidated after tough year
AstraZeneca’s Alexion hopes to extend dominance in PNH as Big Pharma competitors close in
Takeda’s Poseida partnership starts to pay off with promising hemophilia A gene therapy data
Axonics nabs Canadian nod for 20-year incontinence implant requiring fewer recharges
Gates, Bezos back $75M round for Synchron’s drill-free brain-computer interface implant
45 days later, BioCryst abandons another program, citing stiff competition
Innovent plucks Chinese rights to LG Chem’s gout disease treatment in nearly $100M deal
Lam Research to trim 7% of workforce, increase R&D spending as memory-chip crunch hits outlook
U.S. economy doesn’t look as good as GDP suggests